We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (257)
- Legislation (84)
- COVID-19 (66)
- Compliance and enforcement (51)
- Vaping hub (46)
- Manufacturing (29)
- Import and export (22)
- Labelling and packaging (20)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (13)
- Weight loss products (6)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
712 result(s) found, displaying 576 to 600
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Regulatory decision noticesDirection Notice issued to cease advertising of unregistered therapeutic goods to consumers
-
Media releasesAn individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China
-
Media releasesInfringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products
-
Media releasesInformation on how supplements are regulated in Australia
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection
-
Media releasesThe Federal Court has imposed substantial penalties on Peptide Clinics Australia
-
Media releasesRisks associated with cosmetic injections can be related to both the product and the experience of the person performing the procedure
-
Media releasesThe TGA has clarified that state and territory governments will continue to regulate fluoridated drinking water in Australia
-
Media releasesThe TGA is urging Australians to return unused prescription pain relief medicines to their local pharmacy
-
Media releasesThe 2019 TGA stakeholder survey is open. Have your say before 5 July
-
Media releasesWe're encouraging all Australians to return their unused opioids to their local pharmacy
-
Media releasesInternational work-sharing initiative approves Niraparib (Zejula®)
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Media releasesReasons for releasing guidance and how it was developed
-
Media releasesOn Thursday 30 May 2019, the Therapeutic Goods Administration (TGA) executed four search warrants connected to a business operating in the Sutherland Shire, Sydney
-
Media releasesThe TGA has seized black salve products after executing a search warrant at a business premises on the Gold Coast
-
Media releasesCourt action continues against Peptide Clinics Australia for alleged advertising breaches
-
Media releasesTGA data analysis
-
Media releasesSecond candidate in international work-share initiative
-
Media releasesInvitation to comment on discussion paper now published
-
Update to the advertising complaints and investigation information database improves search features
Media releasesThis update implements feedback from stakeholders to make the database more user-friendly -
Regulatory decision noticesDirection Notice issued to cease advertisement of prescription and illegal products
-
Media releasesThe TGA is alerting consumers to the potential risks of purchasing electronic cigarette liquid